Open Access iconOpen Access

REVIEW

crossmark

Mechanisms adopted by cancer cells to escape apoptosis–A review

SAYEQUA DANDOTI*

Department of Basic Sciences, Deanship of Preparatory Year & Supporting Studies, Imam Abdulrahman Bin Faisal University, Dammam, 34212, Saudi Arabia

* Address correspondence to: Sayequa Dandoti, email

BIOCELL 2021, 45(4), 863-884. https://doi.org/10.32604/biocell.2021.013993

Abstract

Inactivation of apoptosis is the prime phenomenon in cancer development and cancer treatments. Mutations in the apoptotic pathway not only exert resistance to apoptosis and provide a survival advantage to cancer cells but also confer resistance to cancer therapies. Escaping apoptosis is the “hallmark” of cancer cells. Cancer cells can withstand many apoptotic stimuli, such as DNA damage, unfavorable environments, and cytotoxic therapies. Substantial research has been carried out and is in good progress on the various mechanisms adopted by cancer cells to evade apoptosis. This article reviews the apoptosis escape mechanisms by cancer cells, viz. apoptotic gene alterations (in few essential and accessory apoptotic genes), post-translational modifications (phosphorylation and ubiquitination of apoptotic proteins), metabolic alterations, mitochondrial alterations, immunity escape, epigenetics, cancer cell dormancy, cancer clonal theory, and reversibility of apoptosis. The review reveals that there is a wide scope for further research to address the various challenges in realizing successful cancer therapies that involve reversing the apoptotic resistance and/or inducing apoptosis in tumor cells.

Keywords


Cite This Article

DANDOTI, S. (2021). Mechanisms adopted by cancer cells to escape apoptosis–A review. BIOCELL, 45(4), 863–884.

Citations




cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 3067

    View

  • 1447

    Download

  • 0

    Like

Share Link